| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 17.021 | 44.321 | 51.049 | 55.581 | 71.566 | 88.658 | 90.140 | 94.932 | 96.183 |
| Total Income - EUR | - | 17.021 | 44.324 | 51.053 | 55.584 | 71.677 | 88.676 | 90.164 | 94.944 | 100.347 |
| Total Expenses - EUR | - | 4.433 | 14.440 | 16.527 | 16.888 | 20.190 | 21.038 | 22.756 | 29.450 | 28.866 |
| Gross Profit/Loss - EUR | - | 12.588 | 29.884 | 34.527 | 38.695 | 51.487 | 67.637 | 67.408 | 65.494 | 71.481 |
| Net Profit/Loss - EUR | - | 12.076 | 28.554 | 32.995 | 36.994 | 49.750 | 65.031 | 65.607 | 64.704 | 68.609 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Oncolog Medserv Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 139 | 0 | 0 | 0 | 0 | 495 | 71 | 0 | 0 |
| Current Assets | - | 13.994 | 30.720 | 36.245 | 37.612 | 50.162 | 65.528 | 68.939 | 82.221 | 87.949 |
| Inventories | - | 192 | 0 | 0 | 0 | 62 | 0 | 0 | 44 | 0 |
| Receivables | - | 4.164 | 2.580 | 80 | 3.787 | 4.255 | 7.350 | 56.196 | 13.251 | 76.462 |
| Cash | - | 9.638 | 28.140 | 36.165 | 33.825 | 45.845 | 58.178 | 12.743 | 68.926 | 11.488 |
| Shareholders Funds | - | 12.121 | 28.607 | 33.047 | 37.045 | 49.800 | 65.079 | 65.655 | 81.150 | 68.677 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.012 | 2.113 | 3.238 | 567 | 362 | 944 | 3.355 | 1.070 | 19.272 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oncolog Medserv Srl